Combination Product Regulation Will Come Under Scrutiny At May 1 Meeting

AdvaMed members will have an opportunity to voice concerns over combination product regulation at a May 1 meeting with FDA Combination Products Program Director Mark Kramer

More from Archive

More from Medtech Insight